Long Noncoding RNA Signatures as Cancer Biomarkers
Journal of Clinical Oncology · 2023
DOI: 10.1200/jco.23.00381 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Clinical Oncology, 2023. Verfasst von Aina M Mas und 1 weiteren Autor:innen. Beteiligte Einrichtung: Center for Applied Medical Research, University of Navarra, Pamplona, Spain. Hauptthemen laut MEDLINE: RNA, Long Noncoding, Neoplasms. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 60 Literaturangaben.
Abstract (Originalsprache)
Article Tools UNDERSTANDING THE PATHWAY Article Tools OPTIONS & TOOLS Export Citation Track Citation Add To Favorites Rights & Permissions COMPANION ARTICLES Long Noncoding RNA Expression Independently Predicts Outcome in Pediatric Acute Myeloid Leukemia. February 16, 2023 ARTICLE CITATION DOI: 10.1200/JCO.23.00381 Journal of Clinical Oncology - published online before print April 12, 2023 PMID: 37043713 Long Noncoding RNA Signatures as Cancer Biomarkers Aina M. Mas , PhD1,2xAina M. MasSearch for articles by this author and Maite Huarte , PhD1,2xMaite HuarteSearch for articles by this author Show More 1Center for Applied Medical Research, University of Navarra, Pamplona, Spain2Institute of Health Research of Navarra (IdiSNA), Pamplona, Spain https://doi.org/10.1200/JCO.23.00381 First Page Full Text PDF Figures and Tables © 2023 by American Society of Clinical OncologySUPPORTSupported by PID2020-113683GB-100/funded by MCIN/AEI/10.13039/501100011033, La Caixa Foundation (LCF/PR/HR21/00176), European Research Council Consolidator 771425, and Worldwide Cancer Research 20-0204 grants (M.H.); and Ministerio de Economía y Competitividad REF: BES2015-074569 cofounded by FSE (A.M.M.).AUTHOR CONTRIBUTIONSConception and design: All authorsManuscript writing: All authorsFinal approval of manuscript: All authorsAccountable for all aspects of the work: All authorsAUTHORS' DISCLOSURES OF POTENTIAL CONFLICTS OF INTERESTLong Noncoding RNA Signatures as Cancer BiomarkersThe following represents disclosure information provided by authors of this manuscript. All relationships are considered compensated unless otherwise noted. Relationships are self-held unless noted. I = Immediate Family Member, Inst = My Institution. Relationships may not relate to the subject matter of this manuscript. For more information about ASCO's conflict of interest policy, please refer to www.asco.org/rwc or ascopubs.org/jco/authors/author-center.Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments).No potential conflicts of interest were reported. Companion Long Noncoding RNA Expression Independently Predicts Outcome in Pediatric Acute Myeloid Leukemia
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Center for Applied Medical Research, University of Navarra, Pamplona, Spain.
- Institute of Health Research of Navarra (IdiSNA), Pamplona, Spain.
ORCID-Profile: Aina M Mas, Maite Huarte
Zitieren
APA
Mas, A. M., & Huarte, M. (2023). Long Noncoding RNA Signatures as Cancer Biomarkers. Journal of Clinical Oncology. https://doi.org/10.1200/jco.23.00381
Vancouver
Mas AM, Huarte M. Long Noncoding RNA Signatures as Cancer Biomarkers. Journal of Clinical Oncology. 2023. doi:10.1200/jco.23.00381
BibTeX
@article{Mas2023,
author = {Mas, Aina M and Huarte, Maite},
title = {Long Noncoding RNA Signatures as Cancer Biomarkers},
journal = {Journal of Clinical Oncology},
year = {2023},
doi = {10.1200/jco.23.00381}
}
EUVIMED